UPC | Universe Pharmaceuticals INC Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.6110 - 0.6429
52 Week Range	0.6110 - 64.80
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	234,638
Average Volume	1,842,653
Shares Outstanding	2,103,180
Market Cap	1,339,726
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2021-03-23

Valuation
Profitability
Growth
Health
P/E Ratio	-0.01
Forward P/E Ratio	N/A
EPS	-76.35
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	225
Country	China
Website	UPC

Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.

UPC's peers: AKAN, CPHI, IMCC, PRFX, SNOA, RGC, VRTHF, EGRX, SGBI, QLI, RAPH, GSAC, SSIC, PROC, SHPHF, PAHC, PROCW, TKNO, SHMN

*Chart delayed

Analyzing fundamentals for UPC we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see UPC Fundamentals page.

Watching at UPC technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on UPC Technicals page.